Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

39 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Risk of residual cancer after complete response following first-line chemotherapy in men with metastatic non-seminomatous germ cell tumour and International Germ Cell Cancer Cooperative Group intermediate/poor prognosis: A multi-institutional retrospective cohort study.
Antonelli L, Ardizzone D, Ravi P, Bagrodia A, Mego M, Daneshmand S, Nicolai N, Nazzani S, Giannatempo P, Franza A, Heidenreich A, Paffenholz P, Saoud R, Eggener S, Ho M, Oswald N, Olson K, Tryakin A, Fedyanin M, Naoun N, Javaud C, Fizazi K, King JM, Adra N, Douglawi A, Cary C, Sweeney C, Fankhauser CD. Antonelli L, et al. Among authors: fedyanin m. Eur J Cancer. 2023 Mar;182:144-154. doi: 10.1016/j.ejca.2022.12.032. Epub 2023 Jan 20. Eur J Cancer. 2023. PMID: 36787661 Free article.
Intratumoral Heterogeneity of SMAD4 Immunohistochemical Expression and Its Role in Prediction of Recurrence Pattern in Patients with Resectable Pancreatic Cancer.
Pokataev I, Kudaibergenova A, Artemyeva A, Popova A, Rumyantsev A, Podluzhny D, Kudashkin N, Fedyanin M, Tryakin A, Tjulandin S. Pokataev I, et al. Among authors: fedyanin m. J Gastrointest Cancer. 2019 Sep;50(3):478-484. doi: 10.1007/s12029-018-0103-6. J Gastrointest Cancer. 2019. PMID: 29675723
Dose-reduced first cycle of chemotherapy for prevention of life-threatening acute complications in nonseminomatous germ cell tumor patients with ultra high tumor markers and/or poor performance status.
Tryakin A, Fedyanin M, Bulanov A, Kashia S, Kurmukov I, Matveev V, Fainstein I, Gordeeva O, Zakharova T, Tjulandin S. Tryakin A, et al. Among authors: fedyanin m. J Cancer Res Clin Oncol. 2018 Sep;144(9):1817-1823. doi: 10.1007/s00432-018-2695-4. Epub 2018 Jul 5. J Cancer Res Clin Oncol. 2018. PMID: 29974210
39 results